Related Experiment Video
Updated: Jul 26, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention
Yang Liu1, Lei Li1, Zhen Wang1
1The Affiliated Hospital of Shandong University of TCM, Jinan 250011, China.
Insights
Myocardial infarction leads to heart failure via ischemia/reperfusion (I/R) injury. Understanding I/R mechanisms like mitochondrial dysfunction and ROS is crucial for developing new treatments for heart disease.
Area of Science:
- Cardiology
- Molecular Medicine
- Biochemistry
Background:
- Cardiovascular diseases are a leading cause of mortality globally.
- Myocardial infarction is a major contributor to ischemic heart failure.
- Ischemia/reperfusion (I/R) injury is a critical factor in myocardial damage.
Purpose of the Study:
- To explore the molecular and cellular mechanisms of myocardial I/R injury.
- To identify key pathways involved in post-ischemic cardiac remodeling.
- To highlight the clinical significance of developing therapeutic strategies against I/R injury.
Main Methods:
- Review of existing literature on myocardial I/R injury.
- Analysis of molecular mechanisms including mitochondrial dysfunction, metabolic alterations, inflammation, reactive oxygen species (ROS) production, and autophagy.
- Examination of therapeutic interventions for I/R injury.
Main Results:
- Identified key mechanisms contributing to myocardial I/R injury: mitochondrial dysfunction, metabolic alterations, inflammation, ROS overproduction, and autophagy deregulation.
- Highlighted the persistent challenge of myocardial I/R injury in current cardiovascular treatments.
- Emphasized the need for effective strategies to mitigate I/R injury.
Conclusions:
- Myocardial I/R injury involves complex molecular and cellular pathways.
- Effective therapeutic strategies are needed to prevent or reduce myocardial I/R injury and improve outcomes in heart disease.
- Further research into I/R injury mechanisms is clinically significant.
Abstract:
Cardiovascular diseases are one of the leading causes of mortality in developed countries. Among cardiovascular disorders, myocardial infarction remains a life-threatening problem predisposing to the development and progression of ischemic heart failure. Ischemia/reperfusion (I/R) injury is a critical cause of myocardial injury. In recent decades, many efforts have been made to find the molecular and cellular mechanisms underlying the development of myocardial I/R injury and post-ischemic remodeling. Some of these mechanisms are mitochondrial dysfunction, metabolic alterations, inflammation, high production of ROS, and autophagy deregulation. Despite continuous efforts, myocardial I/R injury remains a major challenge in medical treatments of thrombolytic therapy, heart disease, primary percutaneous coronary intervention, and coronary arterial bypass grafting. The development of effective therapeutic strategies to reduce or prevent myocardial I/R injury is of great clinical significance.
